期刊文献+

毛花苷C促进肝癌SMMC-7721细胞凋亡及抑制survivin的表达 被引量:2

Lanatoside C promotes apoptosis and inhibits survivin expression in hepatocarcinoma SMMC-7721 cells
下载PDF
导出
摘要 目的:通过毛花苷C作用于人肝癌SMMC-7721细胞,研究其对SMMC-7721细胞增殖的影响初步探讨其作用机制.方法:使用不同浓度毛花苷C干预S M M C-7721细胞,通过细胞增殖实验及克隆形成实验,检测毛花苷C对SMMC-7721细胞增殖的作用;通过流式细胞仪检测毛花苷C对SMMC-7721细胞周期和凋亡的影响;采用Western blot技术分析细胞凋亡抑制基因survivin的表达.结果:毛花苷C对SMMC-7721细胞增殖有明显的抑制作用,各加药组与对照组相比差异有统计学意义(P<0.01),并呈现剂量-效应相关关系;流式细胞术显示,毛花苷C将S M M C-7721细胞阻滞于S期,并诱导其凋亡;Western blot检测结果显示毛花苷C下调SMMC-7721细胞内survivin蛋白的表达.结论:毛花苷C明显抑制SMMC-7721细胞增殖,将细胞阻滞在S期并诱导其凋亡.该机制可能与下调survivin的蛋白表达有关. AIM: To investigate the effect of lanatoside C on the proliferation of human hepatocarcinoma SMMC-7721 cells and to explore the underlying mechanism.METHODS: SMMC-7721 cells were treated with lanatoside C. Then cell proliferation assay and colony formation assay were applied to detect the cell proliferation. The effect of lanatoside C on the cell cycle and apoptosis of SMMC-7721 cells were detected by flow cytometry. Western blot assay was used to detect survivin protein expression.RESULTS: Compared with control cells, lanatoside C significantly inhibited the proliferation of SMMC-7721 cells(P 0.01) in a dose-dependent manner. Results of flow cytometry indicated that lanatoside C arrested SMMC-7721 cells at the S phase and induced their apoptosis. Western blot assay showed that lanatoside C down-regulated the expression of survivin protein in SMMC-7721 cells.CONCLUSION: Lanatoside C could inhibit the proliferation of SMMC-7721 cells obviously, arrest the SMMC-7721 cells at S phase and induce their apoptosis. The mechanism may be associated with the down-regulation of survivin expression.
出处 《世界华人消化杂志》 CAS 2016年第9期1331-1341,共11页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.81460458 广西自然科学基金面上项目 No.2015GXNSFAA139157~~
关键词 毛花苷C 细胞凋亡 细胞周期 SURVIVIN 肝癌 Lanatoside C Apoptosis Cell cycle Survivin Hepatocarcinoma
  • 相关文献

参考文献5

二级参考文献27

  • 1刘扬,高愈希,吴刚,陈春英.典型纳米材料生物效应及其毒理学研究的进展[J].中华预防医学杂志,2007,41(2):130-133. 被引量:10
  • 2Burstein H J.The distinctive nature of HER2-positive breast cancers[J].N Engl J Med,2005,353(16):1652-4.
  • 3Wainberg Z A,Anghel A,Desai A J,et al.Lapatinib,a dual EGFR and HER2 kinase inhibitor,selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo[J].Clin Cancer Res,2005,16(5):1509-19.
  • 4Hu S,Zhu Z,Li L,et al.Epitope mapping and structural analysis of an anti-ErbB2 antibody A21:Molecular basis for tumor inhibitory mechanism[J].Proteins,2008,70(3):938-49.
  • 5Polcher M,Rudlowski C,Friedrichs N,et al.In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer[J].BMC Cancer,2010(10):137.
  • 6Campling B G,Haworth A C,Baker H M,et al.Establishment and characterization of a panel of human lung cancer cell lines[J].Cancer,1992,69(8):2064-74.
  • 7van Slooten H J,Bonsing B A,Hiller A J,et al.Outgrowth of BT-474 human breast cancer cells in immune-deficient mice:a new in vivo model for hormone-dependent breast cancer[J].Br J Cancer,1995,72(1):22-30.
  • 8Ooi S M,Vivian J B,Cohen R J.The use of the Ki-67 marker in the pathological diagnosis of the epithelioid variant of renal angiomyolipoma[J].Int Urol Nephrol,2009,41(3):559-65.
  • 9Laakkonen P,Waltari M,Holopainen T,et al.Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth[J].Cancer Res,2007,67(2):593-9.
  • 10Koukourakis M I,Manolas C,Minopoulos G,et al.Angiogenesis relates to estrogen receptor negativity,c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast[J].Int J Surg Pathol,2003,11(1):29-34.

共引文献215

同被引文献23

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部